Casual effects of gut microbiota on the severity of COVID-19: a
two-sample Mendelian randomization and a meta-analysis
Aimin Jiang1†, Zheng Wang1†, Demeng
Xia2†, Peng Luo3, Xinxin
Gan1, Renqi Yao4,5*, Linhui
Wang1*
1 Department of Urology, Changhai Hospital, Naval
Medical University, Shanghai 200433, China
2 Department of Orthopedics, Changhai Hospital, Naval
Medical University, Shanghai, China
3 Department of Oncology, Zhujiang Hospital, Southern
Medical University, Guangzhou 510260, China.
4 Translational Medicine Research Center, Fourth
Medical Center and Medical Innovation Research Division of the Chinese
PLA General Hospital, Beijing 100048, China
5 Department of Burn Surgery, Changhai Hospital, Naval
Medical University, Shanghai 200433, China
† Aimin Jiang, Zheng Wang, and Demeng Xia contributed
equally to this work.
Correspondence:
Linhui Wang, MD, PhD, Department of Urology, Changhai Hospital, No.168
Road, Yangpu District, Shanghai 200433, People’s Republic of China. Tel:
(+86) 13901635510; Email:wanglinhui@smmu.edu.cn
Renqi Yao, MD, Translational Medicine Research Center, Medical
Innovation Research Division and Fourth Medical Center of the Chinese
PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing 100853,
People’s Republic of China. Tel: (+86) 18501689629; Email:yaorenqixx1995@163.com.
Keywords:
Mendelian randomization, SARS-CoV-2, COVID-19, gut microbiota, infection